Marksans Pharma Ltd Half Yearly Results

Gross Sales

1,340.4

1,390.3

1,232.54

1,146.14

1,031.27

Excise Duty

0

0

0

0

0

Net Sales

1,340.4

1,390.3

1,232.54

1,146.14

1,031.27

Other Operating Income

0

0

0

0

0

Other Income

27.21

51.45

14.88

21.33

29.09

Total Income

1,367.61

1,441.76

1,247.42

1,167.47

1,060.36

Total Expenditure

1,095.78

1,132.87

957.29

903.48

815.35

PBIDT

271.83

308.89

290.13

263.99

245.01

Interest

11.88

6.1

5.56

8

3.2

PBDT

259.95

302.79

284.57

255.99

241.81

Depreciation

50.02

43.43

39.95

43.06

31.21

Minority Interest Before NP

0

0

0

0

0

Tax

55.47

62.29

66.3

58.81

54.93

Deferred Tax

-2.87

1.27

-8.51

-6.48

1.38

Reported Profit After Tax

157.34

195.79

186.83

160.61

154.29

Minority Interest After NP

0.77

0.69

1.36

-0.92

2.11

Net Profit after Minority Interest

156.57

195.11

185.47

161.52

152.18

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

156.57

195.11

185.47

161.52

152.18

EPS (Unit Curr.)

3.45

4.31

4.09

3.56

3.36

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

45.32

45.32

45.32

45.32

45.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.27

22.21

23.53

23.03

23.75

PBDTM(%)

-

-

-

-

-

PATM(%)

11.73

14.08

15.15

14.01

14.96